Intrinsic Value of S&P & Nasdaq Contact Us

Vericel Corporation VCEL NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
65/100
4/7 Pass
SharesGrow Intrinsic Value
$171.43
+384.7%
Analyst Price Target
$45.50
+28.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Vericel Corporation (VCEL) trades at a trailing P/E of 102.4, forward P/E of 81.4. Trailing earnings yield is 0.98%, forward earnings yield 1.23%. PEG 1.71. Graham Number is $7.18.

Criteria proven by this page:

  • VALUE (52/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 81.4 (down from trailing 102.4) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 1.71 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield 0.98% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 1.23% as earnings recover.
  • Analyst consensus target $45.50 (+28.6% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 65/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
~
VALUE
52/100
Price-to-Earnings & upside
Proven by this page
FUTURE
67/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
90/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — VCEL

Valuation Multiples
P/E (TTM)102.4
Forward P/E81.4
PEG Ratio1.71
Forward PEG2.27
P/B Ratio4.77
P/S Ratio6.15
EV/EBITDA57.1
Per Share Data
EPS (TTM)$0.33
Forward EPS (Est.)$0.43
Book Value / Share$7.01
Revenue / Share$5.46
FCF / Share$0.69
Yields & Fair Value
Earnings Yield0.98%
Forward Earnings Yield1.23%
Dividend Yield0.00%
Graham Number$7.18
SharesGrow IV$171.43 (+384.7%)
Analyst Target$45.50 (+28.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -3.5 -0.15 2.80 1.27 -
2017 -10.5 0.27 8.06 2.84 -
2018 -86.1 1.40 6.85 7.71 -
2019 -79.5 7.95 6.92 6.52 -
2020 487.6 -3.61 10.40 11.25 -
2021 -244.5 0.69 10.71 11.69 -
2022 -74.3 -0.63 6.46 7.55 -
2023 -532.6 6.58 7.50 8.58 -
2024 258.9 -0.63 9.19 11.31 -
2025 110.3 1.93 5.14 6.59 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.85 $54.38M $-19.57M -36%
2017 $-0.52 $63.92M $-17.29M -27%
2018 $-0.20 $90.86M $-8.14M -9%
2019 $-0.18 $117.85M $-7.91M -6.7%
2020 $0.06 $124.18M $2.86M 2.3%
2021 $-0.16 $156.18M $-7.47M -4.8%
2022 $-0.35 $164.37M $-16.71M -10.2%
2023 $-0.07 $197.52M $-3.18M -1.6%
2024 $0.20 $237.22M $10.36M 4.4%
2025 $0.32 $276.26M $16.52M 6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.43 $0.34 – $0.52 $322.57M $322.47M – $322.67M 6
2027 $0.79 $0.64 – $0.84 $380.48M $377.45M – $383.5M 6
2028 $1.30 $1.07 – $1.52 $443.7M $443.7M – $443.7M 4
2029 $1.65 $1.63 – $1.67 $513.94M $509.54M – $519.17M 2
2030 $2.09 $2.07 – $2.12 $649.36M $643.81M – $655.98M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message